NCT05922644

Brief Summary

Disorders of consciousness (DOC) refers to the persistent loss of consciousness after 28 days in patients with brain injury caused by trauma, stroke, or hypoxia. It includes coma, vegetative state, and minimally conscious state. At present, there is no effective treatment for DOC. Only one RCT study of amantadine has proved that it may be effective for the treatment of DOC. In recent years, more evidence has shown that neuromodulation technology is beneficial to the recovery of DOC. Cervical spinal cord stimulation surgery is a new treatment method for patients with DOC. Electrodes are implanted in the high cervical spinal cord C2-C5. By adjusting different electrical stimulation parameters, it has a wake-promoting effect. In this study, patients were selected into the spinal cord stimulation group and the conventional treatment group according to the wishes of their families. The patients in the spinal cord stimulation group were given 21 days of cervical spinal cord stimulation treatment on the basis of conventional brain rehabilitation. Patients were followed up routinely and completed designated examinations at 12 months to determine the safety and efficacy of cervical spinal cord stimulation therapy.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
344

participants targeted

Target at P75+ for not_applicable

Timeline
52mo left

Started Jul 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress40%
Jul 2023Sep 2030

First Submitted

Initial submission to the registry

May 25, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 28, 2023

Completed
3 days until next milestone

Study Start

First participant enrolled

July 1, 2023

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Expected
4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2030

Last Updated

July 3, 2023

Status Verified

June 1, 2023

Enrollment Period

3.2 years

First QC Date

May 25, 2023

Last Update Submit

June 28, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in consciousness 12 months after surgery assessed by CRS-R

    The primary efficacy indicator is "change in consciousness recovery 12 months after cervical spinal cord electrical stimulation (assessed by the Coma Recovery Scale - Revised (CRS-R), ranges from 0 to 25, with higher scores mean a better outcome)".

    12 months

Secondary Outcomes (1)

  • Consciousness recovery 12 months after surgery assessed by GOS-E

    12 months

Other Outcomes (4)

  • Glasgow Coma Scale (GCS)

    12 months

  • National Institute of Health stroke scale (NIHSS)

    12 months

  • Full Outline of UnResponsiveness (FOUR) Score

    12 months

  • +1 more other outcomes

Study Arms (2)

Spinal cord electrical stimulation group

EXPERIMENTAL

According to the EDC system, patients are randomly assigned to receive 21 days of cervical spinal cord electrical stimulation treatment in addition to routine brain resuscitation and rehabilitation awakening treatment.

Device: SCS

Conventional treatment group

SHAM COMPARATOR

According to the EDC system, patients are randomly assigned to receive only routine brain resuscitation and rehabilitation awakening treatment.

Other: Conventional

Interventions

SCSDEVICE

21 days of cervical spinal cord electrical stimulation treatment in addition to routine brain resuscitation and rehabilitation awakening treatment.

Spinal cord electrical stimulation group

Routine brain resuscitation and rehabilitation awakening treatment.

Conventional treatment group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age between 18 and 65 years old
  • Patients with postoperative consciousness disorders after cerebral hemorrhage for more than 28 days
  • CRS-R score meets the MCS diagnosis
  • Signed informed consent.

You may not qualify if:

  • Secondary brain injury caused by arteriovenous malformation, cerebral aneurysm, cavernous hemangioma, brain tumor and carbon monoxide poisoning
  • History of previous epileptic seizures
  • Critical condition, unstable intracranial condition, risk of rebleeding
  • Unstable vital signs requiring mechanical ventilation
  • Contraindications for spinal cord surgery
  • Severe sympathetic overactivity syndrome.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beijing Tiantan Hospital, Capital Medical University

Beijing, Beijing Municipality, 100050, China

RECRUITING

MeSH Terms

Conditions

ComaStroke

Interventions

Congresses as Topic

Condition Hierarchy (Ancestors)

UnconsciousnessConsciousness DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

OrganizationsHealth Care Economics and Organizations

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
director

Study Record Dates

First Submitted

May 25, 2023

First Posted

June 28, 2023

Study Start

July 1, 2023

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

September 1, 2030

Last Updated

July 3, 2023

Record last verified: 2023-06

Locations